End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
94.1 TWD | -1.05% | +0.21% | -10.81% |
02/05 | PharmaEngine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
24/04 | PharmaEngine, Inc. Announces First Patient Dosed in Phase I Trial of PEP07 for Solid Tumors | CI |
ETFs positioned on PharmaEngine, Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +4.91% | - | |
0.00% | 34 M€ | +4.00% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.81% | 42Cr | |
+64.23% | 6.26TCr | |
-2.31% | 4.12TCr | |
+45.38% | 4.03TCr | |
-8.29% | 2.79TCr | |
+11.97% | 2.62TCr | |
-21.16% | 1.91TCr | |
+7.54% | 1.31TCr | |
+27.17% | 1.21TCr | |
+25.72% | 1.23TCr |
- Stock Market
- Equities
- 4162 Stock
- Funds and ETFs PharmaEngine, Inc.